Armand, P., Janssens, A., Gritti, G., Radford, J., Timmerman, J., Pinto, A., . . . Ansell, S. M. (2021). Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma. Blood.
Citação norma ChicagoArmand, Philippe, et al. "Efficacy and Safety Results From CheckMate 140, a Phase 2 Study of Nivolumab for Relapsed/refractory Follicular Lymphoma." Blood 2021.
Citação norma MLAArmand, Philippe, et al. "Efficacy and Safety Results From CheckMate 140, a Phase 2 Study of Nivolumab for Relapsed/refractory Follicular Lymphoma." Blood 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.